$ENTA
ENANTA PHARMACEUTICALS INC

2022 Q3 Form 10-Q Financial Statement

#000095017022015515 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $20.32M $19.48M $18.72M
YoY Change -13.82% -9.92% -7.03%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.57M $12.93M $10.48M
YoY Change 50.42% 52.52% 25.76%
% of Gross Profit
Research & Development $34.80M $39.09M $42.09M
YoY Change -28.91% -16.82% 1.4%
% of Gross Profit
Depreciation & Amortization $655.0K $716.0K $822.0K
YoY Change -18.73% -12.47% -2.14%
% of Gross Profit
Operating Expenses $47.37M $39.09M $42.09M
YoY Change -17.34% -16.82% 1.4%
Operating Profit -$32.54M -$33.85M
YoY Change -3.86% 13.96%
Interest Expense $714.0K $393.0K $255.0K
YoY Change 114.41% -10.48% -53.64%
% of Operating Profit
Other Income/Expense, Net $393.0K $255.0K
YoY Change -10.48% -53.21%
Pretax Income -$26.33M -$32.15M -$33.59M
YoY Change -21.14% -3.77% 15.22%
Income Tax $14.00K -$447.0K $0.00
% Of Pretax Income
Net Earnings -$26.35M -$31.70M -$33.59M
YoY Change 7.11% 31.95% 52.38%
Net Earnings / Revenue -129.68% -162.74% -179.48%
Basic Earnings Per Share -$1.53 -$1.63
Diluted Earnings Per Share -$1.269M -$1.53 -$1.63
COMMON SHARES
Basic Shares Outstanding 20.72M 20.71M 20.55M
Diluted Shares Outstanding 20.71M 20.55M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $249.2M $253.3M $280.3M
YoY Change 2.14% -1.38% -25.43%
Cash & Equivalents $43.99M $28.37M $40.99M
Short-Term Investments $205.2M $224.9M $239.3M
Other Short-Term Assets $13.45M $11.54M $14.08M
YoY Change -5.24% -4.92% -56.14%
Inventory
Prepaid Expenses
Receivables $20.32M $19.48M $18.72M
Other Receivables $28.72M $28.73M $28.75M
Total Short-Term Assets $311.7M $313.0M $341.9M
YoY Change -2.29% -2.53% -20.16%
LONG-TERM ASSETS
Property, Plant & Equipment $6.173M $4.588M $4.815M
YoY Change 3.87% -30.62% -65.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $29.29M $39.43M $42.22M
YoY Change -72.99% -65.92% 72.32%
Other Assets $696.0K $703.0K $92.00K
YoY Change 656.52% -32.73% -90.8%
Total Long-Term Assets $63.70M $72.18M $64.95M
YoY Change -46.82% -44.17% 64.01%
TOTAL ASSETS
Total Short-Term Assets $311.7M $313.0M $341.9M
Total Long-Term Assets $63.70M $72.18M $64.95M
Total Assets $375.4M $385.2M $406.8M
YoY Change -14.44% -14.48% -13.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.000M $1.245M $5.985M
YoY Change -37.11% -78.88% 5.0%
Accrued Expenses $20.94M $19.19M $21.74M
YoY Change -6.66% 8.45% 38.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.83M $23.04M $30.74M
YoY Change -17.54% -19.53% 15.56%
LONG-TERM LIABILITIES
Long-Term Debt $1.423M $1.506M $1.506M
YoY Change -5.51% 1.83% 0.4%
Other Long-Term Liabilities $454.0K $441.0K $876.0K
YoY Change -18.64% -47.87% -11.87%
Total Long-Term Liabilities $454.0K $441.0K $876.0K
YoY Change -18.64% -47.87% -11.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.83M $23.04M $30.74M
Total Long-Term Liabilities $454.0K $441.0K $876.0K
Total Liabilities $54.08M $47.19M $48.24M
YoY Change 37.38% 44.82% 52.16%
SHAREHOLDERS EQUITY
Retained Earnings -$73.18M -$46.83M -$15.13M
YoY Change -250.65%
Common Stock $398.2M $388.5M $376.8M
YoY Change 13.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $321.3M $338.0M $358.6M
YoY Change
Total Liabilities & Shareholders Equity $375.4M $385.2M $406.8M
YoY Change -14.44% -14.48% -13.04%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$26.35M -$31.70M -$33.59M
YoY Change 7.11% 31.95% 52.38%
Depreciation, Depletion And Amortization $655.0K $716.0K $822.0K
YoY Change -18.73% -12.47% -2.14%
Cash From Operating Activities -$15.53M -$29.60M -$26.38M
YoY Change -26.1% 0.33% 475.87%
INVESTING ACTIVITIES
Capital Expenditures -$1.437M -$251.0K -$74.00K
YoY Change 4254.55% -36.78% -43.08%
Acquisitions
YoY Change
Other Investing Activities $29.67M $16.47M -$34.98M
YoY Change -59.2% -138.03% -236.7%
Cash From Investing Activities $28.23M $16.22M -$35.06M
YoY Change -61.16% -137.12% -237.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.930M 4.120M 3.351M
YoY Change 210.71% 499.71% 191.39%
NET CHANGE
Cash From Operating Activities -15.53M -29.60M -26.38M
Cash From Investing Activities 28.23M 16.22M -35.06M
Cash From Financing Activities 2.930M 4.120M 3.351M
Net Change In Cash 15.63M -9.262M -58.08M
YoY Change -70.29% -87.23% -363.64%
FREE CASH FLOW
Cash From Operating Activities -$15.53M -$29.60M -$26.38M
Capital Expenditures -$1.437M -$251.0K -$74.00K
Free Cash Flow -$14.10M -$29.35M -$26.30M
YoY Change -32.83% 0.83% 491.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#RoyaltyMember
dei Document Type
DocumentType
10-Q
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#RoyaltyMember
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Amendment Flag
AmendmentFlag
false
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#RoyaltyMember
dei Entity Central Index Key
EntityCentralIndexKey
0001177648
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#RoyaltyMember
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14188000
CY2022Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
28728000
CY2021Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
37255000
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35839
dei Entity Registrant Name
EntityRegistrantName
ENANTA PHARMACEUTICALS, INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3205099
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Arsenal Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
607-0800
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
ENTA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20724868
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28367000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57206000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
224921000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
186796000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19479000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23576000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11540000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
313035000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
319021000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
39427000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
108416000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4588000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5943000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23493000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4711000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3968000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
608000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
703000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92000
CY2022Q2 us-gaap Assets
Assets
385214000
CY2021Q3 us-gaap Assets
Assets
438791000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1245000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9540000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19191000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22429000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2599000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4203000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23035000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
36172000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22209000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1126000
CY2022Q2 enta Non Convertible Preferred Stock Liabilities
NonConvertiblePreferredStockLiabilities
1506000
CY2021Q3 enta Non Convertible Preferred Stock Liabilities
NonConvertiblePreferredStockLiabilities
1506000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
441000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
558000
CY2022Q2 us-gaap Liabilities
Liabilities
47191000
CY2021Q3 us-gaap Liabilities
Liabilities
39362000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20720000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20720000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20238000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20238000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
207000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
202000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
388267000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
351033000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3620000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-382000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46831000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48576000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
338023000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
399429000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385214000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
438791000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19479000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21624000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65843000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73499000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39090000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46994000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
129726000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125165000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12929000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8477000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32913000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24180000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
52019000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
55471000
us-gaap Costs And Expenses
CostsAndExpenses
162639000
us-gaap Costs And Expenses
CostsAndExpenses
149345000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-32540000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-33847000
us-gaap Operating Income Loss
OperatingIncomeLoss
-96796000
us-gaap Operating Income Loss
OperatingIncomeLoss
-75846000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
393000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
439000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
942000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1661000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
393000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
439000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
942000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1661000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32147000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33408000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95854000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-74185000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-447000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9384000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-447000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19788000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-31700000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24024000
us-gaap Net Income Loss
NetIncomeLoss
-95407000
us-gaap Net Income Loss
NetIncomeLoss
-54397000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.53
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.70
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.53
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.70
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20710000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20201000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20552000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20155000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20710000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20201000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20552000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20155000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-31700000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24024000
us-gaap Net Income Loss
NetIncomeLoss
-95407000
us-gaap Net Income Loss
NetIncomeLoss
-54397000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-583000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-319000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3238000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1108000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-583000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-319000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3238000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1108000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32283000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24343000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-98645000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55505000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
455580000
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
833000
CY2020Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-534000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4883000
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-439000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-8328000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
451995000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1152000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5280000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-350000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-22045000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
436032000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
686000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5475000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-319000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24024000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
417850000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
399429000
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10409000
CY2021Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-777000
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6062000
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-624000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-30115000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
384384000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3802000
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-451000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6471000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2031000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-33592000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
358583000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4120000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7603000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-583000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-31700000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
338023000
us-gaap Profit Loss
ProfitLoss
-95407000
us-gaap Profit Loss
ProfitLoss
-54397000
us-gaap Share Based Compensation
ShareBasedCompensation
20136000
us-gaap Share Based Compensation
ShareBasedCompensation
15638000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2318000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2528000
enta Premium On Marketable Securities
PremiumOnMarketableSecurities
846000
enta Premium On Marketable Securities
PremiumOnMarketableSecurities
3427000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1118000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1516000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4097000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1868000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2648000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1518000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-8527000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
17529000
enta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-3932000
enta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-4019000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8555000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
195000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3253000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3671000
enta Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3235000
enta Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4343000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
611000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-117000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-232000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-69248000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48975000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
162714000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
307949000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
190068000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
272974000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
688000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
717000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26666000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35692000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18331000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2671000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1228000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
534000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17103000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2137000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25479000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-82530000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57814000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
87739000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32335000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5209000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
412000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
16000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
22984000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3057000
us-gaap Year Founded
YearFounded
1995
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
94000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, management’s judgments with respect to its revenue arrangements; valuation of stock-based awards and the accrual of research and development expenses. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. The future developments of the COVID-19 pandemic also may directly or indirectly impact the Company’s business. The Company has made estimates of the impact of COVID-19 in the Company’s consolidated financial statements as of June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. Actual results could differ from the Company’s estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
277902000
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1506000
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
350031000
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1506000
enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
enta Fair Value Measurements Inter Transfers Between Levels
FairValueMeasurementsInterTransfersBetweenLevels
0
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
267583000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3235000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
264348000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
295210000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
96000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
295212000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
39427000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
108416000
CY2022Q2 enta Accrued Liabilities Manufacturing
AccruedLiabilitiesManufacturing
7614000
CY2021Q3 enta Accrued Liabilities Manufacturing
AccruedLiabilitiesManufacturing
8402000
CY2022Q2 enta Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
4169000
CY2021Q3 enta Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
6062000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4849000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6094000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1443000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
700000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1116000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1171000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19191000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22429000
CY2022Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
87000
CY2021Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
558000
CY2022Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
354000
CY2021Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
0
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
441000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
558000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3852000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.61
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20552000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20155000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
49173000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
764000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
71.97
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
447000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
41.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
149000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
67.64
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4020000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.19
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19959000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4020000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
53.19
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
19959000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2543000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
48.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
18230000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7603000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5475000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20136000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15638000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7603000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5475000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20136000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15638000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
57897000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-31700000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24024000
us-gaap Net Income Loss
NetIncomeLoss
-95407000
us-gaap Net Income Loss
NetIncomeLoss
-54397000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20710000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20201000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.53
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.64
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-31700000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-24024000
us-gaap Net Income Loss
NetIncomeLoss
-95407000
us-gaap Net Income Loss
NetIncomeLoss
-54397000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20710000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20201000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20552000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20155000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20710000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20201000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20552000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20155000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.53
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.70
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4582000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4322000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5558000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6468000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-447000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9384000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19788000
CY2022Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
28728000
CY2021Q4 enta Increase Decrease In Right Of Use Asset And Lease Liability
IncreaseDecreaseInRightOfUseAssetAndLeaseLiability
15076000
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2022Q2 enta Tenant Improvement Allowance
TenantImprovementAllowance
15194
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
76470
CY2022Q2 enta Prepaid Lease Deposit Expense Noncurrent
PrepaidLeaseDepositExpenseNoncurrent
560000
CY2022Q2 us-gaap Security Deposit
SecurityDeposit
3360000
CY2022Q2 enta Tenant Improvement Allowance
TenantImprovementAllowance
2574
CY2022Q2 enta Increase Decrease In Right Of Use Asset And Lease Liability
IncreaseDecreaseInRightOfUseAssetAndLeaseLiability
7425
enta Increase Decrease In Right Of Use Asset And Lease Liability
IncreaseDecreaseInRightOfUseAssetAndLeaseLiability
749
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4738000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6690000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12003000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12363000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
12396000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
65726000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
113916000

Files In Submission

Name View Source Status
0000950170-22-015515-index-headers.html Edgar Link pending
0000950170-22-015515-index.html Edgar Link pending
0000950170-22-015515.txt Edgar Link pending
0000950170-22-015515-xbrl.zip Edgar Link pending
enta-20220630.htm Edgar Link pending
enta-20220630.xsd Edgar Link pending
enta-ex31_1.htm Edgar Link pending
enta-ex31_2.htm Edgar Link pending
enta-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img215115768_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
enta-20220630_def.xml Edgar Link unprocessable
enta-20220630_lab.xml Edgar Link unprocessable
enta-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
enta-20220630_cal.xml Edgar Link unprocessable
enta-20220630_htm.xml Edgar Link completed